Release: SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims on Behalf of Investors of Velocity Financial, Inc. – VEL

Release

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Velocity Financial, Inc. – VEL

5 May 2020

Pomerantz LLP is investigating claims on behalf of investors of Velocity Financial, Inc. (“Velocity” or the “Company”) (NYSE: VEL). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Velocity and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Read full release.

Release: Groupon, Inc. Class Action Alert Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Groupon, Inc.

Release

Groupon, Inc. Class Action Alert Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Groupon, Inc.

5 May 2020

Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Groupon, Inc. (“Groupon” or the “Company”) (NASDAQ: GRPN) in the United States District Court for the Northern District of Illinois on behalf of those who purchased or acquired the securities of Groupon between November 4, 2019 and February 18, 2020, inclusive (the “Class Period”).

Read full release.

Article: If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You’d Have Made 91%

Article - Media, Publications

If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You’d Have Made 91%

Simply Wall St, 05 May 2020

In late January 2021, GameStop experienced a once-in-a-decade squeeze that has captivated the world’s attention. It was a premeditated and programmatic exercise, orchestrated by coordinated stock and option buying across the retail and professional community, resulting in large institutional entities losing billions of dollars. Investment houses with significant short positions did not expect a stock with GameStop’s fundamental profile to increase +2,500% in price over less than three weeks; therefore, they did not have the controls in place to handle the incredible levels of stock and call option purchases. The frenzy drew comments from the White House, provoked a social media crackdown, caused brokerage units to restrict trading, and has led to a Congressional hearing on GameStop on Thursday, February 18th.
Continue reading “Article: If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You’d Have Made 91%”

Article: Wirecard sues Financial Times over investigative reports

Article - Media

Wirecard sues Financial Times over investigative reports

Straits  Times (Singapore), 29 March 2019

Wirecard has filed a suit at the Munich regional court against both the FT and its reporter, Dan McCrum, seeking a ruling on the merits of its case. If successful, the company would then press for monetary redress.

Comment: Use the tag cloud to find other articles about Dan McCrum, suspected to be in collusion with naked short sellers.

Web: Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS

Article - Media

Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS

May 05, 2020 0.6300 0.7300 0.5700 0.5800 0.5800 29,745,000
May 04, 2020 0.5200 0.5300 0.5000 0.5200 0.5200 1,597,600

Comment: NOW LOOK AT THE NEWS Just who would sell all that stock on that GREAT news (only a naked short seller TRAPPED).

Article: Aristides Capital LLC closes position in NLTX / Neoleukin Therapeutics, Inc

Article - Media, Publications

Aristides Capital LLC closes position in NLTX / Neoleukin Therapeutics, Inc

Fintel, 15 May 2020

Aristides Capital LLC has filed a 13F-HR form disclosing ownership of 0 shares of Neoleukin Therapeutics, Inc. (US:NLTX) with total holdings valued at $0 USD as of 2020-03-31. Aristides Capital LLC had filed a previous 13F-HR on 2020-02-13 disclosing 13,900 shares of Neoleukin Therapeutics, Inc. at a value of $171,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter. Other investors with closed positions include Visium Asset Management, LP, Great Point Partners Llc, Perceptive Advisors Llc, Acuta Capital Partners, Llc, and Nomura Asset Management Co Ltd.
Continue reading “Article: Aristides Capital LLC closes position in NLTX / Neoleukin Therapeutics, Inc”

Web: Why is Naked Short Selling Both Illegal and Common Practice?

Web

Why is Naked Short Selling Both Illegal and Common Practice?

First American Stock Transfer, undated

The Depository Trust & Clearing Corporation or DTCC (the final depository where all U.S. trades are settled and cleared) cannot settle fraudulent trades. According to the DTCC website, “We don’t have any power or legal authority to regulate or stop short-selling, naked or otherwise.”

While DTCC may not have the authority to regulate any short selling, it could create computer programs that would track share holdings to determine if they are real shares or simply entitled. Some believe that the DTCC chooses not to monitor these transactions more closely, because they make money on the interest and the loaning of these shares.

Read full article.

Subject: Robert Menendez (D-NJ)

Subject of Interest

U.S. Senator Robert Menendez (D-NJ) is a minority member of the US Senate Committee on Banking. Bob received his B.A. from St. Peter’s College in Jersey City and his law degree from Rutgers University. He served as Chairman of the Senate Foreign Relations Committee in the 113th Congress. He also a Finance Committee member of the Senate Finance Committee and serves on the Subcommittee on Taxation and IRS Oversight and the Subcommittee on Health Care.

Biography

United States Senate Committee on Banking

Subject: Jack Reed (D-RI)

Subject of Interest

U.S. Senator Jack Reed (D-RI) is a minority member of the US Senate Committee on Banking. Reed was elected to Senate in 1996 and has served three terms in the Rhode Island State. Reed earned a master’s degree in public policy from Harvard’s John F. Kennedy School of Government and received a law degree from Harvard Law School. He then became an attorney in private practice, first working as an associate with the law firm of Sutherland, Asbill, & Brennan before moving back to Providence and working for the firm of Edwards & Angell. Reed also served in the U.S. Army and taught economics and international relations as an Associate Professor within the Department of Social Sciences at West Point. He serves on the Appropriations Committee, and Subcommittee on Transportation, Housing, and Urban Development.

Biography

United States Senate Committee on Banking

Subject: Sherrod Brown (D-OH)

Subject of Interest

U. S. Senator Sherrod Brown (D-OH) is a minority member of the US Senate Committee on Banking. He was elected to the Senate in 2007. Prior to serving in the United States Senate, Brown served as a United States Representative for the 13th District, Ohio’s Secretary of State, a member of the Ohio General Assembly, and has taught in Ohio’s public schools and at The Ohio State University. He also serves on the Senate Committee on Finance and has served on the Senate Agriculture, Nutrition, and Forestry Committee, and he served Chairman of the Subcommittee on Jobs, Rural Economic Growth and Energy Innovation.

Biography

United States Senate Committee on Banking

THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?